RU2016114285A3 - - Google Patents

Download PDF

Info

Publication number
RU2016114285A3
RU2016114285A3 RU2016114285A RU2016114285A RU2016114285A3 RU 2016114285 A3 RU2016114285 A3 RU 2016114285A3 RU 2016114285 A RU2016114285 A RU 2016114285A RU 2016114285 A RU2016114285 A RU 2016114285A RU 2016114285 A3 RU2016114285 A3 RU 2016114285A3
Authority
RU
Russia
Application number
RU2016114285A
Other languages
Russian (ru)
Other versions
RU2706693C2 (en
RU2016114285A (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2016114285A publication Critical patent/RU2016114285A/en
Publication of RU2016114285A3 publication Critical patent/RU2016114285A3/ru
Application granted granted Critical
Publication of RU2706693C2 publication Critical patent/RU2706693C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24151—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
RU2016114285A 2013-09-14 2014-09-08 Virus vaccine and methods for production thereof RU2706693C2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN4135/CHE/2013 2013-09-14
PCT/IN2014/000585 WO2015059714A1 (en) 2013-09-14 2014-09-08 Emergency mode in a hybrid vehicle
IN4135CH2013 IN2013CH04135A (en) 2013-09-14 2014-09-08

Publications (3)

Publication Number Publication Date
RU2016114285A RU2016114285A (en) 2017-10-19
RU2016114285A3 true RU2016114285A3 (en) 2018-07-16
RU2706693C2 RU2706693C2 (en) 2019-11-20

Family

ID=52997726

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2016114285A RU2706693C2 (en) 2013-09-14 2014-09-08 Virus vaccine and methods for production thereof

Country Status (6)

Country Link
CN (1) CN105744952A (en)
AU (1) AU2014338520B2 (en)
IN (1) IN2013CH04135A (en)
PH (1) PH12016500500A1 (en)
RU (1) RU2706693C2 (en)
WO (1) WO2015059714A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015148704A1 (en) 2014-03-25 2015-10-01 Terumo Bct, Inc. Passive replacement of media
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
WO2017083286A1 (en) 2015-11-09 2017-05-18 University Of Notre Dame Particle size purification method and devices
US11965175B2 (en) 2016-05-25 2024-04-23 Terumo Bct, Inc. Cell expansion
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
EP3656841A1 (en) 2017-03-31 2020-05-27 Terumo BCT, Inc. Cell expansion
AU2018359556B2 (en) 2017-11-03 2021-12-02 Takeda Vaccines, Inc. Zika vaccines and immunogenic compositions, and methods of using the same
AU2018375789B2 (en) 2017-11-30 2021-11-11 Takeda Vaccines, Inc. Method for inactivating Zika virus and related methods
EP3581646A1 (en) * 2018-06-15 2019-12-18 Themis Bioscience GmbH Integrated manufacturing and chromatographic system for virus production
CN111394321A (en) * 2020-03-30 2020-07-10 无锡加莱克色谱科技有限公司 Ultra-large pore size chromatography medium for virus particle purification and application method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122009000037I2 (en) * 1997-08-28 2011-06-16 Cheil Jedang Corp AN ANALYZED APPROVED JAPANESE ENZEPHALITIS VIRUS TO VERO CELLS AND A VACCINE AGAINST JAPANESE ENZEPHALITIS
KR20120027381A (en) * 2009-05-25 2012-03-21 파나세아 바이오테크 리미티드 Japanese encephalitis vaccine and method of manufacturing the same
CN102100910B (en) * 2009-12-21 2013-01-23 北京清大天一科技有限公司 Method for producing viral vaccines
CN103228293A (en) * 2010-11-30 2013-07-31 巴拉特生物技术国际有限公司 Vaccine formulation for prophylaxis and treatment of chandipura virus infections in mammals
WO2013130001A1 (en) * 2012-02-29 2013-09-06 Ge Healthcare Bio-Sciences Ab Method for endotoxin removal

Also Published As

Publication number Publication date
CN105744952A (en) 2016-07-06
AU2014338520A1 (en) 2016-03-31
WO2015059714A8 (en) 2015-06-18
WO2015059714A1 (en) 2015-04-30
PH12016500500A1 (en) 2016-06-13
RU2706693C2 (en) 2019-11-20
RU2016114285A (en) 2017-10-19
AU2014338520B2 (en) 2019-12-05
IN2013CH04135A (en) 2015-08-14

Similar Documents

Publication Publication Date Title
BR112014018502A2 (en)
BR112014019326A2 (en)
BR112014018516A2 (en)
BR112014017855A2 (en)
BR112014020341A2 (en)
BR112014018480A2 (en)
BR112014017765A2 (en)
BR112016008738A2 (en)
BR112014017669A2 (en)
BR112014021878A2 (en)
BR112014018468A2 (en)
BR112014017901A2 (en)
BR112014018207A2 (en)
BR112014019204A2 (en)
BR112016009458A2 (en)
BR112014017722A2 (en)
BR112015015948A2 (en)
RU2016114285A3 (en)
BR112014018578A2 (en)
BR112014018483A2 (en)
BR112014017794A2 (en)
BR112016004682A2 (en)
BR112015015312A2 (en)
BR112014018353A2 (en)
BR112016013580A2 (en)